Cargando…

Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2

BACKGROUND: Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies. METHODS: We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortés-Borra, Albert, Aranda-Abreu, Gonzalo Emiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891470/ https://www.ncbi.nlm.nih.gov/pubmed/33604795 http://dx.doi.org/10.1007/s43440-021-00231-5

Ejemplares similares

Observational study of people infected with SARS-Cov-2, treated with amantadine
por: Aranda-Abreu, Gonzalo Emiliano, et al.
Publicado: (2020)

Response to: Amantadine, COVID-19 and Parkinsonism
por: Aranda-Abreu, Gonzalo Emiliano
Publicado: (2020)

Amantadine Treatment for People with COVID-19
por: Araújo, Ramiro, et al.
Publicado: (2020)

Amantadine Inhibits SARS-CoV-2 In Vitro
por: Fink, Klaus, et al.
Publicado: (2021)

Amantadine as a drug to mitigate the effects of COVID-19
por: Aranda Abreu, Gonzalo Emiliano, et al.
Publicado: (2020)

Symptoms in patients with asthma infected by SARS-CoV-2
por: Garcia-Pachon, Eduardo, et al.
Publicado: (2021)

The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design
por: Rejdak, Konrad, et al.
Publicado: (2022)

SARS-CoV-2 variants and pregnant Women: A cause for Concern?
por: Onyinyechi Chionuma, Joy, et al.
Publicado: (2022)

Acute necrotizing encephalopathy caused by SARS-CoV-2 in a child
por: Wang, Po-Yuan, et al.
Publicado: (2022)

Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
por: Ciorba, Andrea, et al.
Publicado: (2020)

Tracking the onset date of the community spread of SARS-CoV-2 in western countries
por: Delatorre, Edson, et al.
Publicado: (2020)

SARS-CoV-2 Omicron symptoms and adverse effects of GLP-1 RA therapy
por: Jensterle, Mojca, et al.
Publicado: (2022)

Syncope at SARS-CoV-2 onset
por: Canetta, Ciro, et al.
Publicado: (2020)

Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies
por: Sekirov, Inna, et al.
Publicado: (2021)

Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses
por: Joseph, Jeswin, et al.
Publicado: (2021)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit
por: Krüttgen, Alexander, et al.
Publicado: (2021)

The circulation of Non-SARS-CoV-2 respiratory viruses and coinfections with SARS-CoV-2 during the surge of the Omicron variant
por: Eldesouki, Raghda E., et al.
Publicado: (2022)

Accuracy of Allplex SARS-CoV-2 assay amplification curve analysis for the detection of SARS-CoV-2 variant Alpha
por: Čretnik, Tjaša Ž, et al.
Publicado: (2022)

Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective
por: Elfiky, Abdo A
Publicado: (2022)

SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward
por: Bansal, N., et al.
Publicado: (2022)

Alarming of Severe Respiratory Failure Requiring ECMO Caused by the SARS-CoV-2 Omicron Variant
por: Ohshimo, Shinichiro, et al.
Publicado: (2022)

Favipiravir use for SARS CoV-2 infection
por: Boretti, Alberto
Publicado: (2020)

Sensitivity of SARS‐CoV‐2 to different temperatures
por: Lv, Qi, et al.
Publicado: (2020)

Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples
por: Gupta, Akshita, et al.
Publicado: (2021)

Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
por: Toft-Bertelsen, Trine Lisberg, et al.
Publicado: (2021)

Outbreak caused by the SARS-CoV-2 Omicron variant in the psychiatric ward of a general hospital in Brazil
por: Vanni, Tazio, et al.
Publicado: (2022)

Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2
por: Cerutti, Francesco, et al.
Publicado: (2020)

Potential neuroinvasive and neurotrophic properties of SARS-CoV-2 in pediatric patients: comparison of SARS-CoV-2 with non-segmented RNA viruses
por: Chen, Xiaodi
Publicado: (2020)

Development of a protocol for detection of SARS-CoV-2 in sputum and endotracheal aspirates using Cepheid Xpert Xpress SARS-CoV-2
por: Malczynski, Michael, et al.
Publicado: (2020)

Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2
por: Di Carlo, Daniele, et al.
Publicado: (2021)

Shifts in global bat diversity suggest a possible role of climate change in the emergence of SARS-CoV-1 and SARS-CoV-2
por: Beyer, Robert M., et al.
Publicado: (2021)

The Duration and Determinants of Anti-SARS-CoV-2 Immunoglobulin G in Cancer Patients with SARS-CoV-2 Infection: A Longitudinal Study
por: Jiang, Yao, et al.
Publicado: (2022)

Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus
por: Tuncel, Gulten, et al.
Publicado: (2022)

Prospects for controlling future pandemics of SARS in highlights of SARS-CoV-2
por: Basnet, Buddha Bahadur, et al.
Publicado: (2021)

Olfactory disorder in patients infected with SARS-CoV-2
por: Yen, Yung-Feng, et al.
Publicado: (2021)

Current approaches in laboratory testing for SARS-CoV-2
por: Xu, Yuzhong, et al.
Publicado: (2020)

Laboratory biosafety emergency management for SARS-CoV-2
por: Lin, Kaili, et al.
Publicado: (2020)

A novel fingerprint map for detecting SARS-CoV
por: Gao, Lei, et al.
Publicado: (2006)

Susceptibility of Midge and Mosquito Vectors to SARS-CoV-2
por: Balaraman, Velmurugan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sm2b127643q0ro5mjvhoqqon4l